<p>➀ A recent review in Small emphasizes the need for comprehensive safety evaluations of graphene and its derivatives as they expand into various industries.</p><p>➁ Existing studies reveal a range of biological responses to graphene, highlighting the complexity of their interactions with living organisms.</p><p>➂ The review calls for standardized testing protocols and collaborative efforts among researchers, regulatory bodies, and industry stakeholders to develop robust safety guidelines.</p>